A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophyNathalie Goemans, Yasuhiro Takeshima, Eugenio Mercuri et al.|Neuromuscular Disorders|2017Cited by 128
Localized Lymphoblastic Lymphoma in Children and Adolescents: Results of the LLB‐NHL03 Trial—A Report From the Japan Children's Cancer GroupMasahiro Sekimizu, Shosuke Sunami, Yuki Yuza et al.|Pediatric Blood & Cancer|2025Cited by 0